During the past decade, Sydvestjysk sygehus conducted 60 clinical trials. In the 10-year time frame, 60 clinical trials started and 11 clinical trials were completed, i.e. on average, 18.3% percent of trials that started reached the finish line to date. In the past 5 years, 37 clinical trials started and 7 clinical trials were completed. i.e. 18.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sydvestjysk sygehus" #1 sponsor was "Hospital of South West Jutland" with 11 trials, followed by "University of Southern Denmark" with 7 trials sponsored, "Odense University Hospital" with 5 trials sponsored, "Bayer" with 4 trials sponsored and "Amgen" with 4 trials sponsored. Other sponsors include 45 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sydvestjysk sygehus" #1 collaborator was "Odense University Hospital" with 10 trials as a collaborator, "Aarhus University Hospital" with 6 trials as a collaborator, "Hospital of South West Jutland" with 5 trials as a collaborator, "Region of Southern Denmark" with 5 trials as a collaborator and "Sygehus Lillebaelt" with 5 trials as a collaborator. Other collaborators include 119 different institutions and companies that were collaborators in the rest 102 trials.

According to Clinical.Site data, the most researched conditions in "Sydvestjysk sygehus" are "Quality of Life" (4 trials), "Atherosclerotic Cardiovascular Disease" (3 trials), "Breast Cancer" (3 trials), "Chronic Kidney Disease" (3 trials) and "Hypercholesterolemia" (3 trials). Many other conditions were trialed in "Sydvestjysk sygehus" in a lesser frequency.

Most popular intervention types in "Sydvestjysk sygehus" are "Drug" (43 trials), "Other" (11 trials), "Device" (6 trials), "Diagnostic Test" (6 trials) and "Behavioral" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Eptinezumab" (3 trials), "Antibiotic dosage practice" (2 trials), "Evolocumab" (2 trials) and "Ibrutinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sydvestjysk sygehus" are 74 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Sydvestjysk sygehus". undefined are not yet recruiting, 24 are recruiting, 8 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 33 completed trials in Sydvestjysk sygehus, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Sydvestjysk sygehus, 2 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 21 trials that are defined as “Not Applicable".

Sydvestjysk sygehus has several departments that took part in Clinical trials: "Sydvestjysk Hospital Esbjerg - Cardiology Research Group" - 4 trials